jnj-67571244
Jnj 67571244 is a drug used to treat Leukemia, Myeloid, Acute and Myelodysplastic Syndromes. Jnj 67571244 is being actively studied in 1 study; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Janssen Research & Development, LLC | Barbara Ann Karmanos Cancer Institute | |
| Beth Israel Deaconess Medical Center | ||
| Clinica Univ. de Navarra |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Active, not recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- JNJ-67571244
- Boston, Massachusetts
- +16 more
2021-12-02
Dec 2, 2021